Unitus Seed Fund backs Predible Health
, ET Bureau|
Mar 01, 2018, 10.39 AM IST
NEW DELHI: Predible Health, which runs an artificial intelligence-based cancer radiology platform, has raised an undisclosed amount from impact investor Unitus Seed Fund.
“Unitus’ funding will enable Predible to scale up the development of our cancer AI platform as well as invest in regulatory approvals for our existing products,” said Predible Health chief executive Suthirth Vaidya. “Our clinical validation studies are displaying positive results and we are now working to bring our offerings into clinical practice.”
The startup says it has processed more than two million images since its inception in 2016, and it is aiming to touch 500 million images by December 2020. It currently has tie-ups with healthcare institutions such as Tata Memorial Hospital in Mumbai, Mahajan Imaging in Delhi and Narayana Health in Bengaluru.
Predible Health facilitates cancer diagnosis through its artificial intelligence powered clinical applications for liver and lung cancers which enable radiologists to interpret images faster and with more accuracy. It has developed algorithms to help physicians characterise diseases as well as plan and deliver personalised treatment.
The company has developed two flagship products, including Predible Liver, which assists surgeons with precise planning for liver transplant and tumour resections through instant analysis and 3D visualisation of liver lesions and hepatic structures. Built on the cloud, the solution can be accessed by hospitals across India with an internet connection.
“Unitus’ funding will enable Predible to scale up the development of our cancer AI platform as well as invest in regulatory approvals for our existing products,” said Predible Health chief executive Suthirth Vaidya. “Our clinical validation studies are displaying positive results and we are now working to bring our offerings into clinical practice.”
The startup says it has processed more than two million images since its inception in 2016, and it is aiming to touch 500 million images by December 2020. It currently has tie-ups with healthcare institutions such as Tata Memorial Hospital in Mumbai, Mahajan Imaging in Delhi and Narayana Health in Bengaluru.
Predible Health facilitates cancer diagnosis through its artificial intelligence powered clinical applications for liver and lung cancers which enable radiologists to interpret images faster and with more accuracy. It has developed algorithms to help physicians characterise diseases as well as plan and deliver personalised treatment.
The company has developed two flagship products, including Predible Liver, which assists surgeons with precise planning for liver transplant and tumour resections through instant analysis and 3D visualisation of liver lesions and hepatic structures. Built on the cloud, the solution can be accessed by hospitals across India with an internet connection.
